Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Two new San Diego biotechs get $20 million

September 23, 2014 – 11:42 am | Edit Post

Avalon Ventures and GSK have placed $20 million in 2 new San Diego biotech companies.

“100K” Marathon: A Decades-Long Health Study Makes Its Business Case

September 23, 2014 – 3:30 am | Edit Post

For the past several months, 108 people, most of them in the Seattle area, have been under constant biomedical surveillance. And they like it. They’ve agreed to submit to a battery of medical…
[[Click headline to continue reading.]]

Looking Ahead: Whole Eye Transplant Under Development

September 22, 2014 – 11:55 am | Edit Post

The concept of a whole eye transplant seems futuristic, if not impossible. But with a $1million grant from the U.S. Department of Defense, researchers at University of California, San Diego School of Medicine hope to someday make implantation of an entire, functional eye a reality.

San Diego Meets the Xconomists: A Real-World Innovation Commons

September 22, 2014 – 11:52 am | Edit Post

The heat wave broke with impeccable timing, and we were grateful that “California weather” was back as San Diego’s innovation leaders gathered for Xconomy’s sixth annual networking event. Xconomy…
[[Click headline to continue reading.]]

Mapp named a Fierce 15 biotech

September 22, 2014 – 9:49 am | Edit Post

Mapp Biopharmaceutical makes top biotech list.

Good Morning! It’s time to take the Celsius Quiz.

September 22, 2014 – 8:33 am | Edit Post

Celsius Quiz on National Cholesterol Awareness Month

Unique pathway that homes cancer drugs to tumors is like no other

September 22, 2014 – 8:11 am | Edit Post

A new study published in Nature Communications identifies the unique pathway that enhances the delivery of anti-cancer drugs to tumors.

Avalon-GSK Collaboration Generates Two More Startups in San Diego

September 22, 2014 – 6:33 am | Edit Post

San Diego’s Avalon Ventures is taking the wraps off two new startups today, with each one getting as much as $10 million in Series A financing through the partnership that Avalon established early…
[[Click headline to continue reading.]]

Jack Johnson Honored as Outstanding Mentor

September 22, 2014 – 12:00 am | Edit Post

Professor Jack Johnson was nominated with 22 letters of support from current and former trainees.

TSRI Chemists Modify Antibiotic to Vanquish Resistant Bacteria

September 22, 2014 – 12:00 am | Edit Post

The Boger lab has made a powerful analog of vancomycin that is effective against MRSA and other disease-causing bacteria.